[Limited indications for phenotyped blood in the prevention of transfusion-induced anti-red blood cell alloimmunization in chronic kidney failure].
Records from 506 multitransfused patients on a program of hemodialysis were reviewed to evaluate the incidence of transfusion-induced red cell alloimmunization. Out of 405 patients having received a total of 6608 red cell transfusions compatible for A, B and D antigens, only 7 patients (1.72%) developed allo-antibodies which may be attributed to such transfusions. Elaborate red cell phenotyping in non-immunized patients and selection of blood units compatible for other antigens than D does not accordingly appear to be justified and cost-effective.